Xingaoxin Pharmaceutical's Corporate Majority Round

Xingaoxin Pharmaceutical raised a round of funding on September 24, 2018. Investors include Shaanxi Kanghui Pharmaceutical.

Xingaoxin Pharmaceutical (新高新药业) focuses on the research, development and sales of Chinese and Western medicine, health products, cosmetics and medical devices.…

Articles about Xingaoxin Pharmaceutical's Corporate Majority Round: